September 2026 quarter: revenue up 22%, profit up 26%; new finance chief appointed

Management Changes View source PDF Explain this filing

ELANTAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.1%Reaction day

₹12700.00

prior close

₹12350.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+1.4% vs market

Specialty Chemicals peers, median of 99sector+0.4%+1.7% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 1.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

+0.1

15m

+1.8

30m

+0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.1+0.7+1.4+0.4+1.7

Next day

+0.8pendingpending-1.8+2.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 99Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Quarter ended 30 September 2026: revenue from operations rose 22.5% year on year to INR 26,531.39 lakh; net profit rose 25.6% to INR 4,554.55 lakh and EPS was INR 57.45. Nine-month revenue rose 21.9% to INR 77,087.24 lakh and net profit rose 36.1% to INR 14,749.21 lakh. Revenue and profit fell versus June. The company also received permanent revocation of the Ankleshwar closure order and appointed Supriya Bansal as chief financial officer.

Likely market impact

Profit growth supports sentiment, but the sequential fall is a caution. The Ankleshwar reversal aids operations; new finance leadership aids oversight.